Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Bovill: Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator,.... (0.08 sec) 

Hemorrhagic events during therapy with recombinant tissue-type plasminogen …


EG Bovill, ML Terrin, DC Stump, AD Berke, … - Annals of internal …, 1991 - Am Coll Physicians
Interventions: Patients received rt-PA, heparin, and aspirin. The total dose of rt-PA was 150 mg
for the first 520 patients and 100 mg for the remaining 2819 patients. Patients were randomly
assigned to an invasive strategy (coronary arteriography with percutaneous angioplasty ...
Cited by 181 - Related articles - All 3 versions

Hemorrhagic complications associated with the use of intravenous tissue …


RM Califf, EJ Topol, BS George, JM Boswick, C … - The American Journal of …, 1988 - Elsevier
: Quantitation of blood loss during the patients' hospital stay included a median drop in hematocrit
of 11.4 points, a median nadir hematocrit of 31.2, a 14 percent rate of significant clinically evident
bleeding, and a 31 percent rate of transfusion of two or more units of blood. All of these ...
Cited by 86 - Related articles - All 4 versions

Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in …


P Tanswell, U Tebbe, KL Neuhaus, L … - Journal of the …, 1992 - Am Coll Cardio Found
Pharmacokinetics and fibrin specificity of alteplase (recombinant tissue-type plasminogen
activator) were determined in 10 patients with acute myocardial infarction undergoing an accelerated
infusion regimen during the alteplase/anistreplase patency study (TAPS). Fifteen ...
Cited by 79 - Related articles - All 4 versions

[CITATION] and the TIMI Investigators. Intracerebral hemorrhage, cerebral infarction, and …


JM Gore, M Sloan, TR Price, AMY Randall, E Bovill, D … - Circulation, 1991
Cited by 60 - Related articles

[CITATION] The University of Nottingham


JR Hampton - Personal communication
Cited by 10 - Related articles

[CITATION] Effect of intravenous tissue-plasminogen activator on infarct size, left ventricular …


F Van de Werf, AER Arnold… - Br Med J, 1988
Cited by 12 - Related articles

[CITATION] GUSTO-I Investigators. Relation of increased arterial blood pressure to mortality …


PE Aylward, RG Wilcox, JH Horgan, HD White - Reactions, 1996
Cited by 16 - Related articles

Bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary …


JD Marmur, S Poludasu, A Agarwal, P … - JOURNAL OF …, 2006 - invasivecardiology.com
Several large randomized clinical trials and meta-analyses have shown that inhibition of platelet
aggregation with platelet glycoprotein IIb/IIIa inhibitors (GPI) improves outcomes in patients presenting
with acute coronary syndromes and in those undergoing percutaneous coronary ...
Cited by 22 - Related articles - Cached - BL Direct - All 3 versions

Pharmacokinetics and haemostatic status during consecutive infusions of …


E Seifried, P Tanswell, D Ellbrück, W Haerer, … - Thrombosis and …, 1989 - ncbi.nlm.nih.gov
Pharmacokinetics and systemic effects of recombinant tissue-type plasminogen activator
(rt-PA) were determined during coronary thrombolysis in 12 acute myocardial infarction patients
using a consecutive intravenous infusion regimen. Ten mg rt-PA were infused in 2 ...
Cited by 41 - Related articles

Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary …


HS Mueller, AK Rao, SA Forman - Journal of the American …, 1987 - Am Coll Cardio Found
Coronary recanalization rates and changes in plasma proteins of the fibrinolytic system were
evaluated with two preparations of recombinant tissue-type plasminogen activator (rt-PA): the
early formulation in liquid excipient ("old" rt-PA) and the later lyophilized form ("new" ...
Cited by 80 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 

Go to Google Home - About Google - About Google Scholar

©2009 Google